CPTx
McDavid Stilwell is an experienced financial executive currently serving as Chief Financial Officer at CPTx since February 2025. Prior to this role, McDavid held positions as Interim Chief Financial Officer at iCell Gene Therapeutics from March to October 2024 and as Chief Financial Officer and Executive Vice President at Coherus BioSciences between October 2020 and December 2023. McDavid's earlier experience includes serving as Senior Vice President of Communications & Investor Relations at Sangamo Therapeutics, Inc. from November 2016 to October 2020 and as Vice President of Corporate Communications and Business Development at Orexigen Therapeutics from March 2012 to November 2016. McDavid holds an MBA from Harvard Business School and a BA in Philosophy and Mathematics from St. John's College.
This person is not in any teams
This person is not in any offices
CPTx
At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform support multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.